Treatment disparities following the diagnosis of an astrocytoma

Journal of Neuro-Oncology

Volumn 101, Issue 1, 2011, Pages 67-74

  Sherwood, Paula R ^a,b   Dahman, Bassam A ^c   Donovan, Heidi S ^a   Mintz, Arlan ^b   Given, Charles W ^d   Bradley, Cathy J ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Astrocytoma; Brain tumor; Chemotherapy; Disparity; Income; Race; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT;

AFRICAN AMERICAN; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HEALTH CARE DISPARITY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OVERALL SURVIVAL; RACE DIFFERENCE; RISK ASSESSMENT; SELF REPORT;

AFRICAN AMERICANS; ASTROCYTOMA; BRAIN NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MEDICAID; MEDICARE; MICHIGAN; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; STANDARD OF CARE; UNITED STATES;

EID: 78651330125     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0223-8     Document Type: Article

References (31)

1. CBTRUS (2008) Statistical report: primary brain tumors in the United States, 2000-2004. Central Brain Tumor Registry of the United States, Chicago
2. NCCN (2008) Central nervous system cancers, vol 1. National Comprehensive Cancer Network Inc
3. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 1:CAS:528:DC%2BD2MXit1Wksbk%3D 10.1056/NEJMoa043330 15758009 (Pubitemid 40349501)
4. J Kennedy I Tuleu K Mackay 2008 Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed J Manag Care Pharm 14 553 560 18693779
5. J Basu 2001 Access to primary care: the role of race and income J Health Soc Policy 13 57 73 1:STN:280:DC%2BD3M7mtlahuw%3D%3D 10.1300/J045v13n04-04 11263100
6. DT McCall A Sauaia RF Hamman JE Reusch P Barton 2004 Are low-income elderly patients at risk for poor diabetes care? Diabetes Care May 27 1060 1065 10.2337/diacare.27.5.1060 (Pubitemid 38579766)
7. U Sambamoorthi S Collins S Crystal 2001 Dually eligible individuals with AIDS: characteristics and health services use J Health Soc Policy 14 19 35 1:STN:280:DC%2BD3M3ptFagtQ%3D%3D 10.1300/J045v14n01-02 11374296 (Pubitemid 32982957)
8. CJ Bradley B Dahman CW Given 2008 Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid J Clin Oncol 26 5067 5073 10.1200/JCO.2008.16.3071 18794546
9. EG Walsh WD Clark 2002 Managed care and dually eligible beneficiaries: challenges in coordination Health Care Financ Rev 24 63 82 12545599
10. Ryan J, Super N (2003) Dually eligible for Medicare and Medicaid: two for one or double jeopardy? Issue Brief Natl Health Policy Forum 794: 1-24
11. PW Groeneveld SB Laufer AM Garber 2005 Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000 Med Care 43 320 329 10.1097/01.mlr.0000156849.15166.ec 15778635 (Pubitemid 40515621)
12. TL Mark KJ Axelsen L Mucha Y Sadkova 2007 Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients Am J Manag Care 13 Suppl 3 S72 S79 17596115
13. Percy C, Shanmugratnam K, Whelan S, Parkin DM, Jack A, Fritz A, Sobin L (2005) ICD-O international classification of diseases for oncology, 3rd edn. World Health Organization, Switzerland
14. Buck C (2008) 2009 ICD-9-CM, vol 1, 2, & 3. Saunders, Philadelphia
15. Allison PD (2001) Missing data. Sage Publications, Thousand Oaks, CA
16. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383 1:STN:280:DyaL2s7ms1GnsQ%3D%3D 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
17. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 613 619 1:STN:280:DyaK38zgtVeqsA%3D%3D 10.1016/0895-4356(92)90133-8 1607900
18. CN Klabunde AL Potosky JM Legler JL Warren 2000 Development of a comorbidity index using physician claims data J Clin Epidemiol 53 1258 1267 1:STN:280:DC%2BD3M%2FptlSrtQ%3D%3D 10.1016/S0895-4356(00)00256-0 11146273 (Pubitemid 32007842)
19. LM Baldwin CN Klabunde P Green W Barlow G Wright 2006 In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 44 745 753 10.1097/01.mlr.0000223475.70440.07 16862036 (Pubitemid 44284265)
20. F Keime-Guibert O Chinot L Taillandier, et al. 2007 Radiotherapy for glioblastoma in the elderly N Engl J Med 356 1527 1535 1:CAS:528: DC%2BD2sXkt1Sjtrs%3D 10.1056/NEJMoa065901 17429084 (Pubitemid 46588417)
21. SM Magrini U Ricardi R Santoni, et al. 2006 Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers Int J Radiat Oncol Biol Phys 65 788 799 10.1016/j.ijrobp.2006.01.026 16682131 (Pubitemid 43795845)
22. SM Chang IF Parney W Huang, et al. 2005 Patterns of care for adults with newly diagnosed malignant glioma JAMA 293 557 564 1:CAS:528:DC%2BD2MXhtVWqsL4%3D 10.1001/jama.293.5.557 15687310 (Pubitemid 40171237)
23. Zhang H, Kane RL, Dowd B, Feldman R (2008) Selection bias and utilization of the dual eligibles in Medicare and Medicaid HMOs. Health Serv Res
24. P Carcaise-Edinboro CJ Bradley 2008 Influence of patient-provider communication on colorectal cancer screening Med Care 46 738 745 10.1097/MLR.0b013e318178935a 18580394
25. AR Green A Peters-Lewis S Percac-Lima, et al. 2008 Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center J Gen Intern Med 23 834 840 10.1007/s11606-008-0572-6 18350339
26. A White CC Liu R Xia, et al. 2008 Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002 Cancer 113 3400 3409 10.1002/cncr.23924 18932248
27. SH Kim J Ferrante BR Won M Hameed 2008 Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment World J Surg Oncol 6 26 10.1186/1477-7819-6- 26 18298840 (Pubitemid 351486702)
28. AM Morris KG Billingsley AJ Hayanga B Matthews LM Baldwin JD Birkmeyer 2008 Residual treatment disparities after oncology referral for rectal cancer J Natl Cancer Inst 100 738 744 10.1093/jnci/djn145 18477800
29. CM Masi S Gehlert 2009 Perceptions of breast cancer treatment among African-American women and men: implications for interventions J Gen Intern Med 24 408 414 10.1007/s11606-008-0868-6 19101776
30. JS Barnholtz-Sloan VL Williams JL Maldonado, et al. 2008 Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma J Neurosurg 108 642 648 10.3171/JNS/2008/108/4/0642 18377240 (Pubitemid 351498955)
31. JT Robertson BC Gunter GW Somes 2002 Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee Br J Neurosurg 16 562 566 1:STN:280:DC%2BD3s7gsVagsg%3D%3D 12617237